医療視覚検査サービスの市場規模、シェア、動向分析レポート：製品別、技術別、最終用途別、地域別、セグメント別予測、2025年～2030年

医療視覚検査サービス市場の成長と動向

Grand View Research, Inc.の最新レポートによると、医療視覚検査サービスの世界市場規模は、2025～2030年にかけてCAGR 9.97％を記録し、2030年までに70億8,000万米ドルに達する見込みです。

同市場の成長は、コスト削減、品質保証の向上、品質管理プロセスの革新、業務効率の向上など、医療視覚検査がもたらすメリットに起因しています。また、医薬品や医療機器では、検査プロセスによって品質が向上するため、メーカーのコストがさらに削減されます。

さらに、視覚検査システムは、医療企業の能力を活用し、品質管理基準のさらなる向上、コスト効率の向上、生産プロセスの最適化をサポートし、ダイナミックな産業情勢の中で競合を維持します。さらに、優れた製品を安定的に提供し、無駄を省き、効率的に運営することで、最終的に成長と成功を後押しします。

さらに、自動化、人工知能（AI）、機械学習は、市場を活性化させる主要要因の一部です。製造業者は、効率を高め、人的ミスを減らし、欠陥検出を改善するために、医療視覚検査を選択するようになってきています。また、バイオ医薬品の研究開発（R& D）への投資の増加や、確立された研究開発・製造受託機関（CDMO）、製造受託機関（CMO）、研究開発受託機関（CRO）の存在感が高まっていることも、市場開拓に寄与しています。

さらに、FDA、EMA、MHRAによる厳格な規制要件により、医療の視覚検査サービスは、医薬品・医療機器製品の安全性、有効性、コンプライアンスを確保するために不可欠なものとなっています。その上、USP<790>、USP <1790>、EU GMP Annex 1のような規格は、粒子状物質の検出と検査システムの改善に必要です。従って、コンプライアンスを遵守するために、ほとんどのメーカーはリアルタイムデータ分析、予知保全、AI主導の欠陥分類を統合し、規制遵守を確実にし、リコールを最小限に抑えています。

したがって、医療企業は、自動化、リアルタイムのコンプライアンスモニタリング、AI支援による意思決定のための目視検査サービスにシフトしています。これらの進歩は、精度、効率、製品の安全性を向上させ、高品質の医療製造の確保における技術革新の重要性を強化しています。そのため、これらのサービスに対するニーズが高まり、視覚検査のアウトソーシングが増加し、新興のパイプラインで費用対効果が高く専門的な専門知識を求めるようになっています。このような要因が、推定期間にわたって市場を牽引していくと予想されます。

医療視覚検査サービス市場レポートハイライト

• 医薬品セグメントが市場を独占し、2024年のシェアは65.15%。このセグメントの成長は、医薬品と医療機器の品質保証への注目が高まっていることに起因しています。さらに、コスト効率、製品コンプライアンス、製品の安全性への関心の高まりが、同セグメントの成長を促進すると予想されます。
• 技術別では、半自動視覚検査（SAVI）セグメントが2024年に最大の市場シェアを占めました。これは、厳しい規制要件、医療機器・医薬品の需要増加、自動化の急速な導入に起因します。その上、半自動化は、注射な液体、粉末、凍結乾燥製品を運ぶアンプル、バイアル、カートリッジ、シリンジを簡単かつ実用的に検査することができます。
• 最終用途別では、製薬・バイオ製薬企業が市場を独占し、2024年には49.82％を占めます。これは、医薬品需要の増加、疾病負担の増加、コスト効率サービスの上昇、研究開発投資の増加、製品の安全性への関心の高まりに起因します。
• 北米市場は2024年に40.68%の最大市場シェアを占めました。アウトソーシング需要の高まりと、米国、カナダ、北米といった国々における確立された市場参入企業の存在が、市場を牽引すると予想されます。さらに、米国で効率的な医療視覚検査サービスを提供する同地域内の既存市場参入企業は、市場成長を促進する主要因の1つです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 医療視覚検査サービス市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 技術の進歩
• 臨床検査件数分析（2024年）
• 医療視覚検査サービス市場分析ツール
  • 産業分析-ポーターの5つの分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 医療視覚検査サービス市場：製品別、推定・動向分析

• 医療視覚検査サービス市場、製品別：セグメントダッシュボード
• 医療視覚検査サービス市場、製品別：変動分析
• 製品別、2018～2030年
• 製薬
• 医療機器

第5章 医療視覚検査サービス市場：技術別、推定・動向分析

• 医療視覚検査サービス市場、技術別：セグメントダッシュボード
• 医療視覚検査サービス市場、技術別：変動分析
• 技術別、2018～2030年
• 手動目視検査（MVI）
• 半自動目視検査（SAVI）
• 自動視覚検査（AVI）

第6章 医療視覚検査サービス市場：最終用途別、推定・動向分析

• 医療視覚検査サービス市場、最終用途別：セグメントダッシュボード
• 医療視覚検査サービス市場、最終用途別：変動分析
• 最終用途別、2018～2030年
• 製薬・バイオ医薬品企業
  • 製薬・バイオ医薬品企業市場、2018～2030年、
• 医療機器企業
  • 医療機器企業市場、2018～2030年、
• その他
  • その他市場、2018～2030年、

第7章 医療視覚検査サービス市場：地域別、推定・動向分析

• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 世界地域市場スナップショット
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • タイ
  • 韓国
  • オーストラリア
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 市場参入企業の分類
• 企業市場シェア分析、2023/24年
• 企業プロファイル
  • Catalent, Inc.
  • Charles River Laboratories
  • Jabil Inc.
  • Lonza Group
  • Grand River Aseptic Manufacturing.
  • Vetter Pharma
  • NIVAGEN
  • Recipharm AB
  • Samsung Biologics
  • SGS SA
  • West Pharmaceutical Services, Inc.
  • Adragos Pharma.

第9章 主要推奨事項

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 4 Global Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 5 Global Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 6 North America Discovery Outsourcing, by Country, 2018 - 2030 (USD Million)
• Table 7 North America Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 8 North America Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 9 North America Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 10 U.S. Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 11 U.S. Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 12 U.S. Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 13 Canada Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 14 Canada Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 15 Canada Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 16 Mexico Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 17 Mexico Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 18 Mexico Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 19 Europe Discovery Outsourcing, by Country, 2018 - 2030 (USD Million)
• Table 20 Europe Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 21 Europe Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 22 Europe Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 23 UK Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 24 UK Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 25 UK Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 26 France Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 27 Germany Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 28 Germany Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 29 Germany Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 30 France Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 31 France Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 32 Italy Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 33 Italy Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 34 Italy Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 35 Spain Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 36 Spain Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 37 Spain Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 38 Denmark Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 39 Denmark Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 40 Denmark Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 41 Sweden Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 42 Sweden Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 43 Sweden Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 44 Norway Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 45 Norway Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 46 Norway Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific Discovery Outsourcing, by Country, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 51 Japan Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 52 Japan Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 53 Japan Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 54 China Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 55 China Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 56 China Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 57 India Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 58 India Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 59 India Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 60 Thailand Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 61 Thailand Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 62 Thailand Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 63 South Korea Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 64 South Korea Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 65 South Korea Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 66 Australia Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 67 Australia Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 68 Australia Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 69 Latin America Discovery Outsourcing, by Country, 2018 - 2030 (USD Million)
• Table 70 Latin America Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 71 Latin America Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 72 Latin America Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 73 Brazil Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 74 Brazil Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 75 Brazil Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 76 Argentina Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 77 Argentina Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 78 Argentina Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 79 Middle East & Africa Discovery Outsourcing, by Country, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 83 South Africa Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 84 South Africa Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 85 South Africa Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 89 UAE Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 90 UAE Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 91 UAE Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 92 Kuwait Healthcare Visual Inspection Services Market, by Product, 2018 - 2030 (USD Million)
• Table 93 Kuwait Healthcare Visual Inspection Services Market, by Technology, 2018 - 2030 (USD Million)
• Table 94 Kuwait Healthcare Visual Inspection Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 95 Financial performance

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Market formulation & validation
• Fig. 6 Commodity flow analysis
• Fig. 7 Value-chain-based sizing & forecasting
• Fig. 8 QFD model sizing & forecasting
• Fig. 9 Bottom-up approach
• Fig. 10 Market snapshot
• Fig. 11 Segment snapshot 1
• Fig. 12 Segment snapshot 2
• Fig. 13 Competitive landscape snapshot
• Fig. 14 Parent market outlook, 2024 (USD Billion)
• Fig. 15 Ancillary market outlook, 2024 (USD Billion)
• Fig. 16 Healthcare Visual Inspection Services Market dynamics
• Fig. 17 Porter's five forces analysis
• Fig. 18 PESTEL analysis
• Fig. 19 Healthcare Visual Inspection Services Market: Product outlook and key takeaways
• Fig. 20 Healthcare Visual Inspection Services Market: Product movement analysis
• Fig. 21 Pharmaceutical market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Medical Device market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Healthcare Visual Inspection Services Market: Technology outlook and key takeaways
• Fig. 24 Healthcare Visual Inspection Services Market: Technology movement analysis
• Fig. 25 Manual Visual Inspection (MVI) market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Semi-Automated Visual Inspection (SAVI) market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Automated Visual Inspection (AVI) market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Healthcare Visual Inspection Services Market: End Use outlook and key takeaways
• Fig. 29 Healthcare Visual Inspection Services Market: End Use movement analysis
• Fig. 30 Pharmaceutical & Biopharmaceutical Companies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Medical Device Companies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Regional Marketplace: Key Takeaways
• Fig. 34 North America Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Key country dynamics
• Fig. 36 U.S. Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Key country dynamics
• Fig. 38 Canada Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Key country dynamics
• Fig. 40 Mexico Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Europe Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Key country dynamics
• Fig. 43 UK Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Key country dynamics
• Fig. 45 Germany Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Key country dynamics
• Fig. 47 France Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Key country dynamics
• Fig. 49 Italy Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Key country dynamics
• Fig. 51 Spain Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Key country dynamics
• Fig. 53 Denmark outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Key country dynamics
• Fig. 55 Sweden outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Key country dynamics
• Fig. 57 Norway outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Asia Pacific Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Key country dynamics
• Fig. 60 Japan Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Key country dynamics
• Fig. 62 China Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Key country dynamics
• Fig. 64 India Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Key country dynamics
• Fig. 66 Thailand Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Key country dynamics
• Fig. 68 South Korea Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Key country dynamics
• Fig. 70 Australia Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Latin America Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Key country dynamics
• Fig. 73 Brazil Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Key country dynamics
• Fig. 75 Argentina Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 MEA Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Key country dynamics
• Fig. 78 South Africa Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Fig. Key country dynamics
• Fig. 80 Saudi Arabia Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 81 Key country dynamics
• Fig. 82 UAE Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 83 Key country dynamics
• Fig. 84 Kuwait Healthcare Visual Inspection Services Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 85 Key company categorization
• Fig. 86 Service heat map analysis
• Fig. 87 Strategic framework

Healthcare Visual Inspection Services Market Growth & Trends:

The global healthcare visual inspection services market size is expected to reach USD 7.08 billion by 2030, registering a CAGR of 9.97% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growth in the market can be attributed to benefits offered by healthcare visual inspection, such as cost savings, increased quality assurance, revolutionizing quality control processes, and enhanced operational efficiency. Besides, in pharmaceutical and medical devices, the inspection process improves the quality, further saving costs for manufacturers.

In addition, visual inspection systems support healthcare companies in harnessing their capabilities, further elevating their quality control standards, driving cost efficiencies, and optimizing production processes to stay competitive in the dynamic industrial landscape. It further supports delivering superior products consistently, reducing waste, and efficiently operating, ultimately fueling growth and success.

Moreover, automation, artificial intelligence (AI), and machine learning are some of the key factors fueling the market. Manufacturers are increasingly opting for healthcare visual inspection to enhance efficiency, reduce human error, and improve defect detection. Besides, rising investments in biopharmaceutical research and development (R&D) and growing presence of established contract development and manufacturing organizations (CDMOs), contract manufacturing organizations (CMOs), and contract research organizations (CROs) contribute to market growth.

Moreover, stringent regulatory requirements from the FDA, EMA, and MHRA have made healthcare visual inspection services essential for ensuring the safety, efficacy, and compliance of pharmaceutical and medical device products. Besides, standards like USP <790>, USP <1790>, and EU GMP Annex 1 are necessary for particulate matter detection and improved inspection systems. Hence, to comply, most manufacturers are integrating real-time data analytics, predictive maintenance, and AI-driven defect classification to ensure regulatory adherence and minimize recalls.

Hence, healthcare companies are shifting towards visual inspection services for automation, real-time compliance monitoring, and AI-assisted decision-making. These advancements enhance precision, efficiency, and product safety, reinforcing the importance of innovation in ensuring high-quality healthcare manufacturing. Therefore, this has led to an increasing need for these services, leading to increasing outsourcing of visual inspections and seeking cost-effective and specialized expertise with their emerging pipelines. Such factors are expected to drive the market over the estimated period.

Healthcare Visual Inspection Services Market Report Highlights:

• The pharmaceutical segment dominated the market, with a share of 65.15% in 2024. Growth in the segment can be attributed to the increasing focus on quality assurance of pharmaceutical products & medical devices. In addition, cost efficiency, product compliance, and a growing focus on product safety are expected to drive the segment growth.
• Based on technology, the semi-automated visual inspection (SAVI) segment held the largest market share in 2024, attributed to the stringent regulatory requirements, growing demand for medical devices & pharmaceutical drugs, and rapid adoption of automation. Besides, semi-automation offers an easy and practical examination of ampoules, vials, cartridges, and syringes carrying injectable liquids, powders, or freeze-dried products.
• Based on the end use, the pharmaceutical and biopharmaceutical companies segment dominated the market, accounting for 49.82% in 2024. This is attributable to increasing pharmaceutical drug demand, the growing burden of diseases, rising cost-efficiency service, growing R&D investment, and a growing focus on product safety.
• North America market held the largest market share of 40.68% in 2024. The growing demand for outsourcing and the presence of established market players in countries like the U.S., Canada, and North America is expected to drive the market. Furthermore, established market players within the region offering efficient healthcare visual inspection services in the U.S. is one of the key factors propelling the market growth.

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Technology
  • 1.2.3. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Parent Market Analysis
• 1.8. List Of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Healthcare Visual Inspection Services Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Technological Advancements
• 3.4. Clinical trials volume analysis (2024)
• 3.5. Healthcare Visual Inspection Services Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's Five Analysis
  • 3.5.2. PESTEL Analysis
  • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Healthcare Visual Inspection Services Market: Product Estimates & Trend Analysis

• 4.1. Healthcare Visual Inspection Services Market, By Product: Segment Dashboard
• 4.2. Healthcare Visual Inspection Services Market, By Product: Movement Analysis
• 4.3. Healthcare Visual Inspection Services Market Estimates & Forecasts, By Product, 2018 - 2030
• 4.4. Pharmaceutical
  • 4.4.1. Pharmaceutical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Medical Device
  • 4.5.1. Medical Device Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Healthcare Visual Inspection Services Market: Technology Estimates & Trend Analysis

• 5.1. Healthcare Visual Inspection Services Market, By Technology: Segment Dashboard
• 5.2. Healthcare Visual Inspection Services Market, By Technology: Movement Analysis
• 5.3. Healthcare Visual Inspection Services Market Estimates & Forecasts, By Technology, 2018 - 2030
• 5.4. Manual Visual Inspection (MVI)
  • 5.4.1. Manual Visual Inspection (MVI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Semi-Automated Visual Inspection (SAVI)
  • 5.5.1. Semi-Automated Visual Inspection (SAVI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Automated Visual Inspection (AVI)
  • 5.6.1. Automated Visual Inspection (AVI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Healthcare Visual Inspection Services Market: End Use Estimates & Trend Analysis

• 6.1. Healthcare Visual Inspection Services Market, By End Use: Segment Dashboard
• 6.2. Healthcare Visual Inspection Services Market, By End Use: Movement Analysis
• 6.3. Healthcare Visual Inspection Services Market Estimates & Forecasts, By Drug Type, 2018 - 2030
• 6.4. Pharmaceutical & Biopharmaceutical Companies
  • 6.4.1. Pharmaceutical & Biopharmaceutical Companies Market, 2018 to 2030, (USD Million)
• 6.5. Medical Device Companies
  • 6.5.1. Medical Device Companies Market, 2018 to 2030, (USD Million)
• 6.6. Others
  • 6.6.1. Others Market, 2018 to 2030, (USD Million)

Chapter 7. Healthcare Visual Inspection Services Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. North America
  • 7.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. U.S
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Thailand
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. South Korea
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Australia
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Company Market Share Analysis, 2023/24
• 8.3. Company Profiles
  • 8.3.1. Catalent, Inc.
    • 8.3.1.1. Company Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Service Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. Charles River Laboratories
    • 8.3.2.1. Company Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Service Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Jabil Inc.
    • 8.3.3.1. Company Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Service Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Lonza Group
    • 8.3.4.1. Company Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Service Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. Grand River Aseptic Manufacturing.
    • 8.3.5.1. Company Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Service Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Vetter Pharma
    • 8.3.6.1. Company Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Service Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. NIVAGEN
    • 8.3.7.1. Company Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Service Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. Recipharm AB
    • 8.3.8.1. Company Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Service Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Samsung Biologics
    • 8.3.9.1. Company Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Service Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. SGS SA
    • 8.3.10.1. Company Overview
    • 8.3.10.2. Financial Performance
    • 8.3.10.3. Service Benchmarking
    • 8.3.10.4. Strategic Initiatives
  • 8.3.11. West Pharmaceutical Services, Inc.
    • 8.3.11.1. Company Overview
    • 8.3.11.2. Financial Performance
    • 8.3.11.3. Service Benchmarking
    • 8.3.11.4. Strategic Initiatives
  • 8.3.12. Adragos Pharma.
    • 8.3.12.1. Company Overview
    • 8.3.12.2. Financial Performance
    • 8.3.12.3. Service Benchmarking
    • 8.3.12.4. Strategic Initiatives

Chapter 9 Key Recommendations